Blood containing high levels of antibodies to heat shock protein 65 (hsp65) were found to be at increased risk of subsequent cardiovascular events. [electronic resource]
Producer: 20021223Description: e9052-8 p. digitalISSN:- 1524-4539
- Aged
- Anti-Arrhythmia Agents -- therapeutic use
- Anticoagulants -- therapeutic use
- Autoantibodies -- blood
- Bacterial Proteins
- Blood Vessel Prosthesis Implantation -- adverse effects
- Cardiovascular Diseases -- blood
- Chaperonin 60
- Chaperonins -- immunology
- Cholesterol -- immunology
- Clinical Trials as Topic -- statistics & numerical data
- Complement Inactivator Proteins -- therapeutic use
- Coronary Artery Bypass -- standards
- Female
- Fibrinolytic Agents -- therapeutic use
- Filtration -- instrumentation
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- adverse effects
- Male
- Neoplasms -- chemically induced
- Patient Education as Topic -- methods
- Platelet Aggregation Inhibitors -- therapeutic use
- Stents -- adverse effects
No physical items for this record
Publication Type: News; Portrait; Comment
There are no comments on this title.
Log in to your account to post a comment.